Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation

NCT ID: NCT06719258

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-20

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

When mechanical ventilation is initiated, a humidification method should be chosen. There is two methods: heat and humidity exchanger filters or heated humidity. The second method is recognized to be more efficient, but many external factors can influence its performance. Insufficient humidity results in observable problems, such as difficult management of respiratory secretions.

The study compare two heated humidifiers already used in ICU.

Data will be collected retrospectively from June 1, 2021.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Humidifier Lung Mechanical Fragility Respiratory Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MR850

20 subjects on this heating humidifier (Fisher \& Paykel MR850).

MR850

Intervention Type DEVICE

This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.

FP950

20 subjects on this heating humidifier (Fisher \& Paykel FP950).

FP950

Intervention Type DEVICE

This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MR850

This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.

Intervention Type DEVICE

FP950

This humidifier will be used straight away for patients whose intubation is expected to last longer than 24 hours.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old
* Admitted to intensive care
* Under invasive mechanical ventilation with the usual indications for the use of a heated humidifier (prolonged invasive mechanical ventilation and / or protective ventilation requiring high respiratory rates.

Exclusion Criteria

* Mechanical venitilation immediately after surgery (\<24h)
* Imminent extubation or planned intubation of very short duration (\<24h)
* Enrolled in the SAVE-ICU study in the group receiving volatile agents with the AnaConDa system.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

François Lellouche

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Universitaire de Cardiologie et de Pneumologie de Québec

Québec, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

François Lellouche

Role: CONTACT

418-656-8711 ext. 3572

Pierre-Alexandre Bouchard

Role: CONTACT

418-656-8711 ext. 2712

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francois Lellouche

Role: primary

418-656-8711

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-3714

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.